These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36156003)

  • 21. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).
    Bretz AC; Parnitzke U; Kronthaler K; Dreker T; Bartz R; Hermann F; Ammendola A; Wulff T; Hamm S
    J Immunother Cancer; 2019 Nov; 7(1):294. PubMed ID: 31703604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial multi-omics analyses of the tumor immune microenvironment.
    Hsieh WC; Budiarto BR; Wang YF; Lin CY; Gwo MC; So DK; Tzeng YS; Chen SY
    J Biomed Sci; 2022 Nov; 29(1):96. PubMed ID: 36376874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy.
    Shklovskaya E; Rizos H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte-Endothelial Recognition to Foster Tumor Immune Escape.
    Corey DM; Rinkevich Y; Weissman IL
    Cancer Res; 2016 Mar; 76(6):1348-53. PubMed ID: 26719541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.
    Diaz-Cano SJ
    Int J Mol Sci; 2012; 13(2):1951-2011. PubMed ID: 22408433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing.
    Bai R; Cui J
    Front Immunol; 2022; 13():890166. PubMed ID: 35833121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
    Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
    Front Immunol; 2021; 12():624725. PubMed ID: 34084160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
    Haebe S; Shree T; Sathe A; Day G; Czerwinski DK; Grimes SM; Lee H; Binkley MS; Long SR; Martin B; Ji HP; Levy R
    Blood; 2021 May; 137(21):2869-2880. PubMed ID: 33728464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.
    Weir GM; Hrytsenko O; Quinton T; Berinstein NL; Stanford MM; Mansour M
    J Immunother Cancer; 2016; 4():68. PubMed ID: 27777777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the tumor microenvironment for effective immunotherapy.
    Sadeghi Rad H; Monkman J; Warkiani ME; Ladwa R; O'Byrne K; Rezaei N; Kulasinghe A
    Med Res Rev; 2021 May; 41(3):1474-1498. PubMed ID: 33277742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
    Yu W; Lei Q; Yang L; Qin G; Liu S; Wang D; Ping Y; Zhang Y
    J Hematol Oncol; 2021 Nov; 14(1):187. PubMed ID: 34742349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
    Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
    Front Immunol; 2021; 12():688215. PubMed ID: 34305920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic CD8
    Iwahori K
    Adv Exp Med Biol; 2020; 1224():53-62. PubMed ID: 32036604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
    Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
    Front Immunol; 2021; 12():647209. PubMed ID: 33841428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.